Backgrounded Membrane Imaging—A Valuable Alternative for Particle Detection of Biotherapeutics?
Authors:
- 25 May 2023
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 18 (4) , 1575-1593
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Protein Particulate Detection Issues in Biotherapeutics Development—Current StatusAAPS PharmSciTech, 2012
- Aggregates in monoclonal antibody manufacturing processesBiotechnology and Bioengineering, 2011
- Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product DevelopmentPharmaceutical Research, 2010
- Characterization of Particles in Protein Solutions: Reaching the Limits of Current TechnologiesThe AAPS Journal, 2010
- An Industry Perspective on the Monitoring of Subvisible Particles as a Quality Attribute for Protein TherapeuticsJournal of Pharmaceutical Sciences, 2010
- Quantification and Characterization of Subvisible Proteinaceous Particles in Opalescent mAb Formulations Using Micro-Flow ImagingJournal of Pharmaceutical Sciences, 2010
- Understanding and Modulating Opalescence and Viscosity in a Monoclonal Antibody FormulationJournal of Pharmaceutical Sciences, 2010
- Silicone Oil- and Agitation-Induced Aggregation of a Monoclonal Antibody in Aqueous SolutionJournal of Pharmaceutical Sciences, 2009
- Effect of Particle Shape on Anisotropic Packing and Shrinkage Behavior of Tape‐Cast Glass–Ceramic CompositesInternational Journal of Applied Ceramic Technology, 2009
- Silicone Oil Induced Aggregation of ProteinsJournal of Pharmaceutical Sciences, 2005